Akoya Biosciences: Myla Lai-Goldman

Akoya Biosciences has appointed Myla Lai-Goldman to its board of directors. From 1990 to 2008, Lai-Goldman held various roles at Laboratory Corporation of America and its predecessor company, Roche Biomedical Laboratories, including executive vice president, chief medical officer, and chief scientific officer. She is currently the chair of precision medicine company GeneCentric Therapeutics, which she cofounded and for which she previously served as CEO and president. She is also a venture partner with Hatteras Venture Partners and managing partner of Personalized Science, a diagnostic consulting company that she founded in 2008. She is board certified in anatomic and clinical pathology, and received her medical degree from Columbia University College of Physicians and Surgeons.